Evidence map›Paper›PMID 36232889›Full record

ArticleInternational journal of molecular sciences2022

Study on βTCP/P(3HB) Scaffolds-Physicochemical Properties and Biological Performance in Low Oxygen Concentration.

Szymon Skibiński, Joanna P Czechowska, Ewelina Cichoń, Martyna Seta, Agata Gondek, Agnieszka Cudnoch-Jędrzejewska, Anna Ślósarczyk, Maciej Guzik, Aneta Zima

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Szymon SkibińskiFaculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30-059 Krakow, Poland.ORCID 0000-0002-2574-8889
Joanna P CzechowskaFaculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30-059 Krakow, Poland.ORCID 0000-0002-5874-8578
Ewelina CichońFaculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30-059 Krakow, Poland.ORCID 0000-0003-3799-8495
Martyna SetaChair and Department of Experimental and Clinical Physiology, Medical University of Warsaw, Banacha 1b, 02-091 Warsaw, Poland.ORCID 0000-0002-9592-6660
Agata GondekDepartment of Methodology, Medical University of Warsaw, Banacha 1b, 02-091 Warsaw, Poland.
Agnieszka Cudnoch-JędrzejewskaChair and Department of Experimental and Clinical Physiology, Medical University of Warsaw, Banacha 1b, 02-091 Warsaw, Poland.
Anna ŚlósarczykFaculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30-059 Krakow, Poland.
Maciej GuzikJerzy Haber Institute of Catalysis and Surface Chemistry Polish Academy of Sciences, Niezapominajek 8, 30-239 Krakow, Poland.ORCID 0000-0001-7999-6645
Aneta ZimaFaculty of Materials Science and Ceramics, AGH University of Science and Technology, Mickiewicza 30, 30-059 Krakow, Poland.ORCID 0000-0002-1159-1331
AGH University of Krakow · PLMedical University of Warsaw · PLJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences · PL

Funding

AGH University of Science and Technology 16.16.160.557 (2022)National Centre for Research and Development TECHMATSTRATEG2/407507/1/NCBR/2019Research project partly supported by program "Excellence initiative - research university" for the AGH University of Science and Technology
6 · The paper itself

Abstract

The search for new materials for bone regenerative purposes is still ongoing. Therefore, we present a series of newly constructed composites based on β tricalcium phosphate (βTCP) and poly(3-hydroxybutyrate) bacteria-derived biopolymer (P(3HB)) in the form of 3D scaffolds with different pore sizes. To improve the polymer attachment to the βTCP surface, the etching of ceramic sinters, using citric acid, was applied. As expected, pre-treatment led to the increase in surface roughness and the creation of micropores facilitating polymer adhesion. In this way, the durability and compressive strength of the ceramic-polymer scaffolds were enhanced. It was confirmed that P(3HB) degrades to 3-hydroxybutyric acid, which broadens applications of developed materials in bone tissue engineering as this compound can potentially nourish surrounding tissues and reduce osteoporosis. Moreover, to the best of our knowledge, it is one of the first studies where the impact of βTCP/P(3HB) scaffolds on mesenchymal stem cells (MSCs), cultured in lowered (5%) oxygen concentration, was assessed. It was decided to use a 5% oxygen concentration in the culture to mimic the conditions that would be found in damaged bone in a living organism during regeneration. Scaffolds enabled cell migration and sufficient flow of the culture medium, ensuring high cell viability. Furthermore, in composites with etched βTCP, the MSCs adhesion was facilitated by hydrophilic ceramic protrusions which reduced hydrophobicity. The developed materials are potential candidates for bone tissue regeneration. Nevertheless, to confirm this hypothesis, in vivo studies should be performed.

Indexed as

Calcium PhosphatesTissue Engineering3-Hydroxybutyric AcidCitric AcidOxygenPolymersTissue Scaffolds3-Hydroxybutyric Acidbeta-tricalcium phosphateCalcium PhosphatesCitric AcidOxygenPolymersbiomaterialsbone tissue engineeringin vitro studiesmesenchymal stem cellspoly(3-hydroxybutyrate)polyhydroxyalkanoatesscaffoldsβ tricalcium phosphate

Identifiers

PMID36232889
PMCPMC9569667
OpenAlexW4303699649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.